The Housing Supply Chain: Four Companies Waiting for the Same Cycle
Four ASX housing supply chain companies, all in trough-cycle earnings, all waiting for the same recovery. GWA is the only one priced at fair value (A$2.61). Reece trades 32% above our A$10.71, James Hardie 27% above A$27, Fletcher Building 41% above NZ$1.96.
Australia and New Zealand are structurally short of housing, and that much is settled. What is less settled is when the construction recovery actually arrives in earnings, and more importantly, how much of that recovery the market has already paid for. Four building-product companies sit at different points along the residential construction supply chain, each dependent on the same underlying catalyst -- higher housing starts -- but priced by the market in ways that imply very different assumptions about timing and magnitude. Our pipeline fair values for REH, GWA, JHX, and FBU span a range from slightly overvalued to deeply overvalued at current prices, and the spread in those gaps is the most interesting thing about this group.
The four companies span the supply chain: James Hardie (JHX) in fibre cement and composite decking, Reece (REH) in plumbing and HVAC-R distribution, GWA Group in bathroom and kitchen fixtures, and Fletcher Building (FBU) in upstream materials from cement to plasterboard. All four are in trough-cycle earnings, and all four have articulated recovery cases that depend on some combination of lower interest rates, higher housing starts, and more project activity flowing through to their order books. The question our analysis asks is: at what price is that thesis already embedded?
The answer varies considerably: at one end, GWA trades within one percent of our fair value estimate -- the market has not priced in a meaningful recovery premium, nor has it applied a meaningful discount. At the other end, REH trades 32 percent above our fair value and JHX trades 27 percent above, with the market implicitly assuming both earnings recovery and a significant compression in discount rates. FBU, on our framework, is the most starkly overvalued of the four, though the IFRS 16 lease-accounting treatment that underpins that finding is a genuine methodological question that readers should weigh carefully. The table below sets out the scorecard before we work through each company in detail.
Scorecard
| Company | Price | Fair Value | Gap | Credibility | WACC | Rating |
|---|---|---|---|---|---|---|
| REH (Reece) | A$15.88 | A$10.71 | -32.5% | 8.5/10 | 10.4% | Unattractive |
| GWA (GWA Group) | A$2.64 | A$2.61 | -1.1% | 6.7/10 | 8.7% | Fair Value |
| JHX (James Hardie) | A$36.87 | A$27.00 | -27.0% | 7.1/10 | 9.5% | Unattractive |
| FBU (Fletcher Building) | NZ$3.31 | NZ$1.96 | -41.0% | 5.4/10 | 9.8% | Overvalued* |
*FBU's gap is highly sensitive to IFRS 16 lease treatment. Under a pre-IFRS 16 framework, the implied overvaluation narrows materially. See the FBU section.
Key metric: Housing exposure is 100% for all four companies. The relevant variable is mix: each company is split differently between new construction (cyclical) and repair/renovation (more defensive). REH and JHX are more heavily weighted toward new construction starts. GWA's approximately 60% renovation mix provides a partial buffer. FBU's NZ market is at a more extreme construction trough -- residential consents at around 32,000 annually versus a peak of 50,000.
REH -- Reece Limited
Reece is Australia's largest trade distributor of plumbing, waterworks, and HVAC-R products, with 680 branches in ANZ and 286 in the United States. The business model amplifies volume swings through fixed branch costs: in FY25, revenue fell just 1% but EBITDA fell 11%. FY26 EBIT guidance of A$520-540 million represents a 24% trough from the FY24 peak. The US segment is the problem and the opportunity simultaneously, with EBITDA margins falling to 7.2% in HY26 while ANZ holds at 12.7%. Management credibility is 8.5/10, the highest in this group: Peter Wilson's family holds approximately 55% of the company, creating near-perfect alignment, and the family's through-cycle investment posture (A$401 million buyback at trough, 39 net new branches in FY25) positions the company to capture recovery upside.
Our fair value is A$10.71 against a market price of A$15.88, a 32.5% gap. At A$15.88, the implied EV is approximately 12.1 times our FY27 EBITDA estimate versus our model's 7.9 times, with the gap driven by our locked WACC of 10.4% (reflecting the RBA's February 2026 hike) and terminal multiple of 10.0 times below the peer range. The market is pricing both earnings recovery and rate normalisation simultaneously. The counter-argument is real: 100 years of ANZ heritage, gross margins stable at 28-29% through a 30% volume swing, and the US platform represents optionality worth A$3-4 per share if margins recover. Our analysis suggests the stock becomes genuinely interesting below A$11.
GWA -- GWA Group
GWA manufactures and distributes branded bathroom and kitchen products (Caroma holds approximately 37% of the Australian toilet suite market) primarily through plumbing merchants. Crucially, approximately 60% of revenue is renovation and replacement driven on a 15-20 year replacement cycle, largely independent of new housing construction. H1 FY26 showed normalised EBIT of A$39.6 million (+2.9%) on revenue of A$214 million (+2.0%), with volume growing 4.9% while revenue grew only 2.0%, indicating unit gains at the cost of price per unit. ROIC of approximately 14.1% against our 8.7% WACC confirms genuine value creation. The balance sheet is conservatively positioned at 1.2 times net debt/EBITDA.
Our fair value is A$2.61 against a market price of A$2.64, a gap of just 1.1%, making this the most straightforward conclusion in our analysis. The market has priced GWA roughly correctly as a mature, cash-generative yield vehicle at approximately 9.0 times EV/EBITDA with a 5.8% dividend yield. Our bear case (A$2.11, 25% probability) captures further RBA hikes and structural price/mix deterioration; our bull case (A$2.87, 20% probability) requires housing approvals converting to starts by FY27. The asymmetry is not compelling in either direction, which is the point. The risk worth monitoring is channel concentration: Reece controls more than 40% of Australian plumbing distribution, and any shift toward own-brand products would be a material headwind.
JHX -- James Hardie Industries
James Hardie holds approximately 90% of the North American fibre cement market and, since the July 2025 acquisition of AZEK for US$8.4 billion, is the only full exterior envelope provider in North America. The combined business generates approximately US$4.6 billion in annualised revenue. The organic business remains strong: fibre cement has gained approximately 100 basis points of total siding market share per year for more than 15 consecutive years, a secular tailwind that operates independently of housing starts, and pricing power held at +5% ASP growth in Q3 FY26 even as volumes declined mid-single-digit percentages. The acquisition created 3.0 times leverage with US$4.3 billion in debt, making this the most balance-sheet-sensitive name in the group.
Our blended fair value is A$27 against a market price of A$36.87, a 27% gap. At A$36.87, the market implies approximately 14 times FY28 EBITDA, pricing near-full capture of the US$125 million cost synergy target, meaningful conversion of the US$500 million commercial synergy target (which we assess as Low credibility with no precedent), and a housing start recovery to approximately 1.5 million in North America. The market is pricing our bull case, not our base case. The acquisition risk is real: a 20% EBITDA miss at 3.0 times leverage compresses interest coverage below 4.5 times, and the CFO transitioned mid-integration. Our analysis indicates the stock becomes attractive below A$24-25.
FBU -- Fletcher Building (NZ Contrast)
Fletcher Building is the New Zealand contrast case: durable upstream oligopoly positions (cement 60%+ NZ share, plasterboard 65% NZ share) in a market at a more extreme trough than Australia, with NZ residential consents running at around 32,000 per year versus a structural need of 45,000-50,000. The company is in the midst of a major restructuring: A$679 million equity raise in 2025, Construction division divested to VINCI, and a NZ$100 million cost-out program that has delivered NZ$45 million in the first half of FY26. ROIC of 4.3% against a 9.8% WACC means value destruction at current volumes. Management credibility is 5.4/10, reflecting CEO Andrew Reding's 18-month tenure and the scale of turnaround still required.
Our fair value is NZ$1.96 against a market price of NZ$3.31, a 41% gap, though a significant portion reflects methodology: our DCF deducts NZ$1.25 billion in IFRS 16 (international financial reporting standard for leases) operating lease liabilities as debt, reducing equity value by NZ$0.95 per share. Excluding leases narrows the gap to 31%. The recovery triggers are identifiable (NZ consents above 3,000/month, Construction sale completing, OSB plant going live April 2026), but the headwinds are material: the WA pipes class action (provision NZ$155 million, outcome uncapped) and a Distribution division running EBIT-negative on NZ$615 million of invested capital. Our bear case (NZ$0.50, 25% probability) captures a scenario where NZ recovery is delayed beyond FY28 and litigation provisions prove inadequate.
What the Spread in Valuations Tells You
The four companies sit at distinctly different points on the implied-recovery spectrum. GWA has not been re-rated at all, sitting 1.1% from our fair value. JHX has been partially re-rated, with the 27% gap reflecting a market that has priced in fibre cement recovery and an optimistic reading of AZEK synergies but stopped short of pricing the full US$500 million commercial synergy target. REH has been aggressively re-rated, at 12.1 times our FY27 EBITDA estimate, embedding both a full earnings recovery and a compression in discount rates. FBU carries the widest gap on our framework, though the IFRS 16 methodology makes that figure more contested.
The most important observation is that the market has been willing to pay for housing recovery visibility well before the recovery has appeared in earnings. REH and JHX are priced on FY27-28 earnings assumptions that require rate normalisation plus construction volume recovery, a two-variable bet where both variables are uncertain. The February 2026 RBA hike, which surprised markets that had expected a hold, is a reminder that rate normalisation timelines are not guaranteed. GWA, which the market has not re-rated, may offer the better risk-adjusted exposure to a housing turn: defensive on the downside, meaningful volume leverage on the upside, and priced today at fair value rather than at a recovery premium.
Bottom Line
All four companies will benefit when residential construction recovers in Australia and New Zealand. The analytical question is not whether the cycle turns but what investors are paying for that turn today. At GWA, the market has priced in almost nothing -- which is appropriate given the defensive renovation mix, but limits upside. At JHX and REH, the market has priced in a great deal -- a full earnings recovery, rate normalisation, and in JHX's case, significant execution on an unproven synergy programme. Our fair values for both sit 27-33% below current prices, driven primarily by the locked WACC reflecting current rate conditions and terminal multiples benchmarked to peer medians rather than current sector premiums. At FBU, the gap is the widest on our framework, though the IFRS 16 methodology makes that figure more contested than the others. The common thread: housing exposure alone does not create value -- the price paid relative to recovery assumptions is what matters, and across this group, the market has been consistently more optimistic than our analysis on both the timing and the discount rate at which future cash flows should be valued.
Analysis generated by the Alpha Insights AI research pipeline. All fair values are point estimates subject to model uncertainty. This is not financial advice. Do your own research before making investment decisions.